High-Frequency Chest-Wall Oscillation Devices Market Report 2026

High-Frequency Chest-Wall Oscillation Devices Market Overview

• High-Frequency Chest-Wall Oscillation Devices market size has reached to $2.65 billion in 2025 • Expected to grow to $3.77 billion in 2030 at a compound annual growth rate (CAGR) of 7.2% • Growth Driver: Impact of Rising COPD Prevalence on the High-Frequency Chest Wall Oscillation Devices Market • Market Trend: Innovative Advances in Programmable Air Pulse Generators for Enhanced Airway Clearance Therapy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under High-Frequency Chest-Wall Oscillation Devices Market?

High-frequency chest-wall oscillation (HFCWO) devices refer to medical devices used for airway clearance therapy. These devices deliver external mechanical vibrations to the chest wall, which help to mobilize and clear mucus from the lungs. The main types in the high-frequency chest-wall oscillation (HFCWO) devices market include AffloVest, vest-type, SmartVest, and RespirTech. AffloVest is a battery-operated high-frequency chest wall oscillation (HFCWO) device that allows patients to remain fully mobile during airway clearance treatments. The various technologies employed in these devices are percussion, compression, and vibration, catering to different patient populations such as pediatric, adult, and geriatric. These devices are used in various applications, including clinics, hospitals, and others.

What Is The High-Frequency Chest-Wall Oscillation Devices Market Growth Forecast?

The high-frequency chest-wall oscillation devices market size is expected to see strong growth in the next few years. It will grow to $3.77 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to rising aging population with respiratory disorders, growing preference for home healthcare respiratory devices, increasing incidence of cystic fibrosis and bronchiectasis, expansion of outpatient respiratory care services, rising healthcare focus on long-term respiratory disease management. Major trends in the forecast period include rising adoption of home-based airway clearance therapy, growing demand for portable and wearable hfcwo devices, increasing use of hfcwo devices in chronic respiratory care, expansion of pediatric and geriatric airway clearance applications, rising focus on non-invasive respiratory therapy solutions.

Global High-Frequency Chest-Wall Oscillation Devices Market Segmentation

1) By Product Type: Vest-Based HFCWO Devices, Wrap-Around Or Jacket-Based HFCWO Devices, Modular HFCWO Systems 2) By Technology: Pneumatic Oscillation Technology, Mechanical Vibration Technology, Compression–Oscillation Combination Technology 3) By Mobility Or Power Source: Stationary (AC-Powered) HFCWO Devices, Portable (Battery-Powered) HFCWO Devices 4) By Patient Population: Pediatric Patients, Adult Patients, Geriatric Patients 5) By End-Use Setting: Hospitals, Clinics, Home Healthcare Settings, Other Healthcare Facilities Subsegments: 1) By Vest-Based HFCWO Devices: Standard-Fit Vest HFCWO Devices, Adjustable Or Multi-Size Vest HFCWO Devices, Pediatric Vest HFCWO Devices, Adult Vest HFCWO Devices, Geriatric-Optimized Vest HFCWO Devices 2) By Wrap-Around or Jacket-Based HFCWO Devices: Full-Torso Wrap-Around HFCWO Devices, Partial-Coverage Jacket HFCWO Devices, Lightweight / Low-Profile Jacket HFCWO Devices, Easy-Wear HFCWO Devices for Limited-Mobility Patients 3) By Modular HFCWO Systems: Console-Based Modular HFCWO Systems, Portable Modular HFCWO Systems, Interchangeable Vest Or Garment Modular Systems, Upgradable Modular HFCWO Platforms

What Are The Drivers Of The High-Frequency Chest-Wall Oscillation Devices Market?

The rising prevalence of chronic obstructive pulmonary diseases is expected to propel the growth of the high-frequency chest wall oscillation (HFCWO) devices market going forward. Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation. COPD cases are the result of smoking, environmental pollutants, genetic predisposition, and an aging population. High-frequency chest wall oscillation (HFCWO) devices aid in managing chronic obstructive pulmonary disease (COPD) by mobilizing and clearing mucus from the airways, reducing infection risks, enhancing lung function, and improving patient comfort. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australian-based government agency, COPD accounted for 3.6% of the total disease burden in 2023, as compared to causing 4% of all deaths in 2022 (7,691 deaths). Therefore, the rising prevalence of chronic obstructive pulmonary diseases drives the growth of the high-frequency chest wall oscillation (HFCWO) devices market. Rising prevalence of chronic respiratory diseases is expected to propel the growth of the high-frequency chest-wall oscillation devices market going forward. Chronic respiratory diseases refer to long-term conditions that affect the airways and other structures of the lungs, leading to breathing difficulties and reduced lung function. Rising prevalence of chronic respiratory diseases is due to factors such as increasing air pollution, smoking, occupational exposures, and aging populations, which collectively contribute to higher rates of asthma, COPD, and other long-term lung conditions, driving demand for healthcare interventions and management solutions. High-frequency chest-wall oscillation devices support the rising prevalence of chronic respiratory diseases by helping patients clear mucus from the lungs, improving breathing efficiency, reducing respiratory infections, and enhancing overall lung function, which in turn drives demand for advanced respiratory care solutions. For instance, in November 2024, according to the European Environment Agency, a Denmark-based government agency, in 2024, chronic respiratory diseases are the third leading cause of death in EEA countries, causing over 60% of nearly 420,000 annual fatalities. Therefore, the prevalence of chronic respiratory diseases is driving the growth of the high-frequency chest-wall oscillation devices industry.

Key Players In The Global High-Frequency Chest-Wall Oscillation Devices Market

Major companies operating in the high-frequency chest-wall oscillation devices market are Electromed Inc., Tactile Medical, Trudell Medical International, Monaghan Medical Corporation, Respinova Ltd., PARI Medical Holding GmbH, Dymedso Medical, ABM Respiratory Care, Airway Clearance Inc., Sentec AG, Inogen Inc., Smiths Medical, Nihon Kohden Corporation, Getinge AB, Fisher & Paykel Healthcare, Vyaire Medical, Hamilton Medical, Lowenstein Medical, Breath Technologies, Medical Depot Inc.

Global High-Frequency Chest-Wall Oscillation Devices Market Trends and Insights

Major companies operating in the high-frequency chest wall oscillation (HFCWO) devices market are developing programmable air pulse generators to enhance treatment customization and patient comfort. Programmable air pulse generators deliver controlled air pulses at adjustable frequencies and intensities, aiming to mobilize mucus and improve airway clearance in patients with conditions like cystic fibrosis or bronchiectasis. For instance, in November 2023, Electromed Inc., a US-based airway clearance device company, launched the fifth-generation SmartVest clearway airway clearance system for treating respiratory conditions such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and other conditions that require airway clearance therapy. The SmartVest Clearway system uses HFCWO therapy, which delivers alternating air pulses into a vest garment that rapidly compresses and releases the chest wall. The system delivers alternating air pulses into a vest garment that rapidly compresses and releases the chest wall, oscillating airflow within the airways. The SmartVest Clearway is designed to provide therapeutic relief for patients with ineffective secretion clearance due to muscle weakness, inadequate cough, or impaired ventilation.

Regional Outlook

North America was the largest region in the high-frequency chest-wall oscillation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the High-Frequency Chest-Wall Oscillation Devices Market?

The high-frequency chest-wall oscillation devices market consists of revenues earned by entities by providing services such as device manufacturing and sales, rental and leasing, maintenance and repair, clinical training and support, and patient education programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The high-frequency chest-wall oscillation devices market also includes sales of accessories and consumables such as vests, hoses, connectors, and replacement parts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.